Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system.

BACKGROUND

Despite its widespread use, the adverse effects (AEs) of memantine have not been well documented, and there is a need to find new ways to analyze the AEs of memantine.

RESEARCH DESIGN AND METHODS

AEs in which the primary suspected drug was memantine were retrieved from the FAERS database. The proportional report ratio (PRR), reporting odds ratio (ROR), Bayesian confidence propagation neural network (BCPNN), and empirical Bayesian geometric mean (EBGM) were used to detect potential positive signals between memantine and AEs. SAS, MySQL, EXCEL, and R language software were used for data processing and statistical analysis.

RESULTS

This study gathered a total of 5808 reports of AEs associated with memantine. Of these reports, a greater proportion of female patients (51.17%) than male patients (36.33%) had AEs. The AEs reported by FAERS were mainly in psychiatric category ( = 2157, IC025 = 2.69), various neurologic disorders ( = 1608, IC025 = 2.04), systemic disorders and various site reactions ( = 842, IC025 = 1.29). Unexpected ocular adverse events have been reported, ophthalmic vein thrombosis ( = 4, IC025 = 3.47) and scleral discolouration ( = 7, IC025 = 3.1), which may worsen glaucoma.

CONCLUSIONS

This study observed conceivable new AEs signals and may supply important assist for scientific monitoring and threat identification of memantine.